Anti-PD-1 therapy using cemiplimab for advanced cutaneous squamous cell carcinoma in HIV patient: A case report.
advanced cutaneous squamous cell carcinoma
cemiplimab
immunotherapy
skin cancer
squamous cell carcinoma
Journal
Clinical case reports
ISSN: 2050-0904
Titre abrégé: Clin Case Rep
Pays: England
ID NLM: 101620385
Informations de publication
Date de publication:
Dec 2021
Dec 2021
Historique:
received:
29
03
2021
revised:
16
11
2021
accepted:
03
12
2021
entrez:
24
12
2021
pubmed:
25
12
2021
medline:
25
12
2021
Statut:
epublish
Résumé
This is a case of a 60-year-old man living with HIV who presented with advanced cutaneous squamous cell carcinoma. After workup, medical and surgical treatment, and disease recurrence, he achieved a complete response with no unexpected toxicities after immunotherapy with cemiplimab.
Identifiants
pubmed: 34950481
doi: 10.1002/ccr3.5228
pii: CCR35228
pmc: PMC8673230
doi:
Types de publication
Case Reports
Langues
eng
Pagination
e05228Informations de copyright
© 2021 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.
Déclaration de conflit d'intérêts
None.
Références
Nature. 2006 Feb 9;439(7077):682-7
pubmed: 16382236
Lancet. 2016 Apr 9;387(10027):1540-1550
pubmed: 26712084
Prog Tumor Res. 2015;42:55-66
pubmed: 26382943
Nature. 1993 Apr 22;362(6422):758-61
pubmed: 8469287
J Immunother Cancer. 2019 Nov 15;7(1):305
pubmed: 31730010
N Engl J Med. 2016 Nov 10;375(19):1823-1833
pubmed: 27718847
N Engl J Med. 2016 Jun 30;374(26):2542-52
pubmed: 27093365
Nat Rev Cancer. 2012 Mar 22;12(4):252-64
pubmed: 22437870
AIDS. 2014 May 15;28(8):1181-91
pubmed: 24901259
N Engl J Med. 2018 Jul 26;379(4):341-351
pubmed: 29863979
PLoS One. 2015 Jun 17;10(6):e0129550
pubmed: 26083524
Oncotarget. 2017 Feb 21;8(8):13116-13125
pubmed: 28061450
JAMA Oncol. 2019 Sep 1;5(9):1332-1339
pubmed: 31154457
Cancer Biol Med. 2017 Aug;14(3):254-270
pubmed: 28884042
Clin Infect Dis. 2009 Mar 1;48(5):633-9
pubmed: 19202627
JAMA Intern Med. 2017 Nov 1;177(11):1613-1621
pubmed: 28975270
Nat Rev Immunol. 2015 Aug;15(8):486-99
pubmed: 26205583
Ann Oncol. 2018 Feb 1;29(2):517-518
pubmed: 29206889
Nat Rev Immunol. 2018 Feb;18(2):91-104
pubmed: 28990586